Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Leukemia, Lymphoid × enzastaurin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphoma 2 Neoplasms 1 Leukemia, Lymphoid 1 Glioma 1 Brain Neoplasms 1

Interventions

ibrutinib 3 tozasertib 1 thymoglobulin 1 romiplostim 1 pembrolizumab 1 obinutuzumab 1 lucatumumab 1 fludarabine 1 fenebrutinib 1 enzastaurin 1 duvelisib 1 Vincristine 1 Receptors, Chimeric Antigen 1 Methotrexate 1 Hu-Mik-beta-1 monoclonal antibody 1 Dasatinib 1 Cyclophosphamide 1 Busulfan 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00452257 2009-03-19

A Study of Enzastaurin in Patients With Leukemia

Eli Lilly and Company

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Lymphoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡